How do you determine if generic vs. brand formulation of a DMT is the probable cause of worsening multiple sclerosis disease activity?

I based this on the timing of the switch to generic formulations and the duration of stability on brand formulation. For example, if a patient has been on brand DMT with stability for 5 years, then recently changed to generic with disease activity within the first year, I would consider that the gen...